Skip to main content
. 2010 Nov 23;104(1):138–145. doi: 10.1038/sj.bjc.6606017

Figure 4.

Figure 4

Kaplan–Meier survival curve demonstrating percentage of overall survival in patients whose tumours harboured high vs low levels of TACE mRNA in tumour cells (A) and TIMP3 mRNA in stromal cells (B). Overall survival of patients with high TACE and TIMP3 mRNA levels, high TACE or high TIMP3 mRNA levels or low TACE and low TIMP3 mRNA levels in tumour and stromal cells, respectively (C).